Invitae
NVTA
$0.01950
Share price
0.00%
Change (1 day)
-98.61%
Change (1 year)
Invitae (NVTA) - Total debt
Total debt on the balance sheet as of September 2023 : $1.50 B
According to Invitae 's latest financial reports the company's total debt is $1.50 B. A company’s total debt is the sum of all current and non-current debts.
Invitae - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $1.75 B | 1.56% |
| 2021-12-31 | $1.72 B | 283.02% |
| 2020-12-31 | $0.45 B | 41.19% |
| 2019-12-31 | $0.31 B | 309.86% |
| 2018-12-31 | $77.78 M | 74.82% |
| 2017-12-31 | $44.49 M | 225.33% |
| 2016-12-31 | $13.67 M | 34.04% |
| 2015-12-31 | $10.2 M | 188.66% |
| 2014-12-31 | $3.53 M | 76.66% |
| 2013-12-31 | $2 M | 64.69% |
| 2012-12-31 | $1.21 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Celldex Therapeutics CLDX | $2.54 M | -99.83% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | $3.98 M | -99.74% | 🇺🇸 USA |
 CareDx CDNA | $34.22 M | -97.73% | 🇺🇸 USA |